Education
About Us
Working with TipRanks
Follow Us
Cencora (COR)
NYSE:COR
COR Stock Chart & Stats
$359.22
$2.86(1.22%)
At close: 4:00 PM EST
$359.22
$2.86(1.22%)
Day’s Range― - ―
52-Week Range$237.71 - $377.54
Previous CloseN/A
Volume440.68K
Average Volume (3M)977.07K
Market Cap
$69.88B
Enterprise Value$72.99B
Total Cash (Recent Filing)$4.36B
Total Debt (Recent Filing)$7.66B
Price to Earnings (P/E)45.1
Beta0.05
Next Earnings
Feb 04, 2026EPS Estimate
4.05Next Dividend Ex-DateN/A
Dividend Yield0.66%
Share Statistics
EPS (TTM)3.84
Shares Outstanding194,526,080
10 Day Avg. Volume1,062,292
30 Day Avg. Volume977,068
Financial Highlights & Ratios
PEG Ratio7.05
Price to Book (P/B)40.17
Price to Sales (P/S)0.19
P/FCF Ratio18.89
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit7.20
Enterprise Value/Ebitda19.54
Forecast
1Y Price Target
$407.55Price Target Upside13.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Earnings ConsistencyAnalyst highlights consistent earnings execution and prudent guidance as evidence the company can reliably deliver profit growth.
Industry FundamentalsAnalyst notes stabilized generic pricing and removal of major litigation and drug-pricing overhangs, supporting valuation upside and greater confidence in sector growth.
Strategic AcquisitionAnalyst sees the OneOncology acquisition reorienting the portfolio toward higher-growth oncology services, which is expected to accelerate earnings expansion and improve margin mix.
Bears Say
Capital AllocationPausing share repurchases to facilitate the OneOncology deal reduces near-term shareholder returns and could disappoint investors who expected buyback support for the stock.
Customer ConcentrationDependence on a single large client remains a concentration risk that could quickly reverse investor sentiment if that customer's business deteriorates.
Cencora News
COR FAQ
What was Cencora’s price range in the past 12 months?
Cencora lowest stock price was $237.71 and its highest was $377.54 in the past 12 months.
What is Cencora’s market cap?
Cencora’s market cap is $69.88B.
When is Cencora’s upcoming earnings report date?
Cencora’s upcoming earnings report date is Feb 04, 2026 which is in 3 days.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on Nov 05, 2025. The company reported $3.84 earnings per share for the quarter, beating the consensus estimate of $3.787 by $0.053.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora pays a Quarterly dividend of $0.6 which represents an annual dividend yield of 0.66%. See more information on Cencora dividends here
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is 4.05.
How many shares outstanding does Cencora have?
Cencora has 194,526,080 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of $3.84 in its last earnings report, beating expectations of $3.787. Following the earnings report the stock price went up 2.75%.
Which hedge fund is a major shareholder of Cencora?
Currently, no hedge funds are holding shares in COR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cencora Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$407.55 (13.45% Upside)
$407.55 (13.45% Upside)
Blogger Sentiment
Bullish
COR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 385.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.1%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.05%
12-Months-Change
Fundamentals
Return on Equity
144.31%
Trailing 12-Months
Asset Growth
14.14%
Trailing 12-Months
Company Description
Cencora
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
COR Company Deck
COR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cencora reported strong financial performance for fiscal 2025 with significant growth in operating income and EPS. The company raised its long-term guidance and made substantial investments in infrastructure to support future growth. Challenges were noted in the PharmaLex business, resulting in a significant goodwill impairment. However, the overall sentiment is positive due to the strong performance and strategic positioning in the specialty market.View all COR earnings summariesCOR Revenue Breakdown
90.55% U.S. Healthcare Solutions
9.45% International Healthcare Solutions
>-0.01% Intersegment eliminations
COR Stock 12 Month Forecast
Average Price Target
$407.55
▲(13.45% Upside)
Technical Analysis
Ownership Overview
6.82% Insiders
29.32% Mutual Funds
0.64% Other Institutional Investors
35.91% Public Companies and Individual Investors
Options Prices
Currently, No data available
---